Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 25

1.

The Effect of Chronic Activation of the Novel Endocannabinoid Receptor GPR18 on Myocardial Function and Blood Pressure in Conscious Rats.

Matouk AI, Taye A, El-Moselhy MA, Heeba GH, Abdel-Rahman AA.

J Cardiovasc Pharmacol. 2017 Jan;69(1):23-33. doi: 10.1097/FJC.0000000000000438.

PMID:
27676325
2.

Adiponectin resistance in skeletal muscle: pathophysiological implications in chronic heart failure.

Sente T, Van Berendoncks AM, Hoymans VY, Vrints CJ.

J Cachexia Sarcopenia Muscle. 2016 Jun;7(3):261-74. doi: 10.1002/jcsm.12086. Epub 2015 Oct 27. Review.

3.

Obesity-Induced Changes in Adipose Tissue Microenvironment and Their Impact on Cardiovascular Disease.

Fuster JJ, Ouchi N, Gokce N, Walsh K.

Circ Res. 2016 May 27;118(11):1786-807. doi: 10.1161/CIRCRESAHA.115.306885. Review.

PMID:
27230642
4.

Cardiomyocyte Antihypertrophic Effect of Adipose Tissue Conditioned Medium from Rats and Its Abrogation by Obesity is Mediated by the Leptin to Adiponectin Ratio.

Bairwa SC, Rajapurohitam V, Gan XT, Mangat R, Proctor SD, Karmazyn M.

PLoS One. 2016 Jan 5;11(1):e0145992. doi: 10.1371/journal.pone.0145992. eCollection 2016.

5.

Adiponectin downregulation is associated with volume overload-induced myocyte dysfunction in rats.

Wang LL, Miller D, Wanders D, Nanayakkara G, Amin R, Judd R, Morrison EE, Zhong JM.

Acta Pharmacol Sin. 2016 Feb;37(2):187-95. doi: 10.1038/aps.2015.84. Epub 2015 Nov 30.

6.

Effects of simvastatin treatment on serum adiponectin concentrations in patients with dislipidemia.

Moezzi A, Parizadeh SM, Tavallaie S, Mazidi M, Afzali F, Adab A, Ferns G, Ghayour Mobarhan M.

Iran Red Crescent Med J. 2014 Aug;16(8):e6915. doi: 10.5812/ircmj.6915. Epub 2014 Aug 5.

7.

AdipoR1/APPL1 potentiates the protective effects of globular adiponectin on angiotensin II-induced cardiac hypertrophy and fibrosis in neonatal rat atrial myocytes and fibroblasts.

Cao T, Gao Z, Gu L, Chen M, Yang B, Cao K, Huang H, Li M.

PLoS One. 2014 Aug 6;9(8):e103793. doi: 10.1371/journal.pone.0103793. eCollection 2014.

8.

Adiponectin inhibits tumor necrosis factor-α-induced vascular inflammatory response via caveolin-mediated ceramidase recruitment and activation.

Wang Y, Wang X, Lau WB, Yuan Y, Booth D, Li JJ, Scalia R, Preston K, Gao E, Koch W, Ma XL.

Circ Res. 2014 Feb 28;114(5):792-805. doi: 10.1161/CIRCRESAHA.114.302439. Epub 2014 Jan 7.

9.

Angiotensin II reduces cardiac AdipoR1 expression through AT1 receptor/ROS/ERK1/2/c-Myc pathway.

Li L, Zhang ZG, Lei H, Wang C, Wu LP, Wang JY, Fu FY, Zhu WG, Wu LL.

PLoS One. 2013;8(1):e49915. doi: 10.1371/journal.pone.0049915. Epub 2013 Jan 22.

10.

The cardio-protective signaling and mechanisms of adiponectin.

Nanayakkara G, Kariharan T, Wang L, Zhong J, Amin R.

Am J Cardiovasc Dis. 2012;2(4):253-66. Epub 2012 Oct 20.

11.

Association of low plasma adiponectin with early diastolic dysfunction.

Negi SI, Jeong EM, Shukrullah I, Raicu M, Dudley SC Jr.

Congest Heart Fail. 2012 Jul-Aug;18(4):187-91. doi: 10.1111/j.1751-7133.2011.00276.x. Epub 2012 Jan 9.

12.

Adiponectin ameliorates doxorubicin-induced cardiotoxicity through Akt protein-dependent mechanism.

Maruyama S, Shibata R, Ohashi K, Ohashi T, Daida H, Walsh K, Murohara T, Ouchi N.

J Biol Chem. 2011 Sep 16;286(37):32790-800. doi: 10.1074/jbc.M111.245985. Epub 2011 Jul 22.

13.

Adiponectin and cardiovascular health: an update.

Hui X, Lam KS, Vanhoutte PM, Xu A.

Br J Pharmacol. 2012 Feb;165(3):574-90. doi: 10.1111/j.1476-5381.2011.01395.x. Review.

14.

Telmisartan attenuates isoproterenol-induced cardiac remodeling in rats via regulation of cardiac adiponectin expression.

Guo BY, Li YJ, Han R, Yang SL, Shi YH, Han DR, Zhou H, Wang M.

Acta Pharmacol Sin. 2011 Apr;32(4):449-55. doi: 10.1038/aps.2010.231. Epub 2011 Mar 14.

15.

High-fat diet and glucocorticoid treatment cause hyperglycemia associated with adiponectin receptor alterations.

de Oliveira C, de Mattos AB, Biz C, Oyama LM, Ribeiro EB, do Nascimento CM.

Lipids Health Dis. 2011 Jan 18;10:11. doi: 10.1186/1476-511X-10-11.

16.

T-cadherin is critical for adiponectin-mediated cardioprotection in mice.

Denzel MS, Scimia MC, Zumstein PM, Walsh K, Ruiz-Lozano P, Ranscht B.

J Clin Invest. 2010 Dec;120(12):4342-52. doi: 10.1172/JCI43464.

17.

Adiponectin deficiency exacerbates cardiac dysfunction following pressure overload through disruption of an AMPK-dependent angiogenic response.

Shimano M, Ouchi N, Shibata R, Ohashi K, Pimentel DR, Murohara T, Walsh K.

J Mol Cell Cardiol. 2010 Aug;49(2):210-20. doi: 10.1016/j.yjmcc.2010.02.021. Epub 2010 Mar 4.

18.

A new role for the natriuretic peptides: metabolic regulators of the adipocyte.

Costello-Boerrigter LC, Burnett JC Jr.

J Am Coll Cardiol. 2009 Jun 2;53(22):2078-9. doi: 10.1016/j.jacc.2009.02.037. No abstract available.

19.

Targeting the AMPK pathway for the treatment of Type 2 diabetes.

Viollet B, Lantier L, Devin-Leclerc J, Hebrard S, Amouyal C, Mounier R, Foretz M, Andreelli F.

Front Biosci (Landmark Ed). 2009 Jan 1;14:3380-400. Review.

20.

Insulin-like growth factor I receptor signaling is required for exercise-induced cardiac hypertrophy.

Kim J, Wende AR, Sena S, Theobald HA, Soto J, Sloan C, Wayment BE, Litwin SE, Holzenberger M, LeRoith D, Abel ED.

Mol Endocrinol. 2008 Nov;22(11):2531-43. doi: 10.1210/me.2008-0265. Epub 2008 Sep 18.

Supplemental Content

Support Center